no intervantion

OTHER4 trials

Sponsors

Bnai Zion Medical Center, Assuta Medical Center, Rabin Medical Center, Tarian Pharma

Conditions

CLLCOVID-19Chemotherapy Induced Peripheral NeuropathyDepression

Phase 2

Safety and Efficacy Study of TAR-0520 Gel in Prevention of Taxane-induced Peripheral Neuropathy

Not yet recruitingNCT07082764

Tarian PharmaChemotherapy Induced Peripheral Neuropathy

Start: 2025-09-01End: 2026-12-15Target: 30Updated: 2025-07-24

Unknown Phase

Heavy Light Chain in Chronic Lymphocytic Leukemia

Bnai Zion Medical CenterCLL

Start: 2015-01-31End: 2020-01-31Target: 130Updated: 2015-03-04

PET-MRI F-DOPA Activity in the Mesocorticolimbic System and Depressive Symptoms in the Prediction of Treatment Compatibility

Assuta Medical CenterDepression

Start: 2017-03-31End: 2019-03-31Target: 60Updated: 2017-01-20

Neonatal SARS-CoV-2 Anti-spike Protein Receptor-binding Domain Antibodies at Delivery

Rabin Medical CenterCOVID-19

Start: 2021-09-12End: 2022-11-01Target: 58Updated: 2022-10-04